TrialCancer chemotherapy and pharmacology2018

Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma.

John P Fruehauf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.